| Target Price | $72.42 |
| Price | $49.44 |
| Potential | 46.48% |
| Number of Estimates | 25 |
| 25 Analysts have issued a price target Baker Hughes 2027 . The average Baker Hughes target price is $72.42. This is 46.48% higher than the current stock price. The highest price target is $89.25 80.52% , the lowest is $51.51 4.19% . | |
| A rating was issued by 30 analysts: 24 Analysts recommend Baker Hughes to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Baker Hughes stock has an average upside potential 2027 of 46.48% . Most analysts recommend the Baker Hughes stock at Purchase. |
25 Analysts have issued a sales forecast Baker Hughes 2026 . The average Baker Hughes sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
26 Analysts have issued an Baker Hughes EBITDA forecast 2026. The average Baker Hughes EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
28 Baker Hughes Analysts have issued a net profit forecast 2026. The average Baker Hughes net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Freedom Broker |
Sell
➜
Hold
|
Upgrade | Oct 30 2026 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Oct 29 2026 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 29 2026 |
| TD Cowen |
Buy
➜
Buy
|
Unchanged | Oct 29 2026 |
| Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Oct 29 2026 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 29 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Oct 19 2026 |
| Analyst Rating | Date |
|---|---|
|
Upgrade
Freedom Broker:
Sell
➜
Hold
|
Oct 30 2026 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Oct 29 2026 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Oct 29 2026 |
|
Unchanged
TD Cowen:
Buy
➜
Buy
|
Oct 29 2026 |
|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Oct 29 2026 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 29 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Oct 19 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


